President Donald Trump’s executive order on new regulations will likely lead to increased use of internal communications to make drug policy at the FDA, an expert said at an FDAnews…
In a decision that reshapes the patent dance between biosimilar applicants and reference holders — and could affect the course of billions of dollars in the pharmaceutical industry — the…
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"SoCal's Regulus Sinks After AstraZeneca PLC Bails on Lead NASH Drug" ALT"SoCal's Regulus Sinks After AstraZeneca PLC Bails on Lead NASH Drug"June 12, 2017By Alex Keown, BioSpace.com Breaking…
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-stock-positive.jpg" NAME"Why This Tiny New Jersey Biotech Looks Like Oracle in 1986" ALT"Why This Tiny New Jersey Biotech Looks Like Oracle in 1986"June 12, 2017By Mark Terry, BioSpace.com Breaking…
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x470-biogen.jpg" NAME"What Biogen Wants in Return for Financial Assistance of Its $750,000 a Year Drug" ALT"What Biogen Wants in Return for Financial Assistance of Its $750,000 a Year Drug"June…
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Bay Area's Coherus Craters After the FDA Spurns Its Biosimilar for Amgen's Neulasta" ALT"Bay Area's Coherus Craters After the FDA Spurns Its Biosimilar for Amgen's Neulasta"June 12, 2017By…